Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US-2015374758-A1 · Dec 31, 2015 · US
Method of propagating cells
US8986984B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8986984-B2 |
| Application number | US-61866409-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 13, 2009 |
| Priority date | Dec 6, 2000 |
| Publication date | Mar 24, 2015 |
| Grant date | Mar 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A method of collecting embryonic-like stem cells from a placenta which has been treated to remove residual cord blood by perfusing the drained placenta with an anticoagulant solution to flush out residual cells, collecting the residual cells and perfusion liquid from the drained placenta, and separating the embryonic-like cells from the residual cells and perfusion liquid. Exogenous cells can be propagated in the placental bioreactor and bioactive molecules collected therefrom.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of propagating exogenous cells in a placental bioreactor comprising: processing an intact placenta to drain umbilical cord blood, irradiating the endogenous cells of the intact placenta such that no or substantially no viable placental cells remain, introducing exogenous cells into the intact placenta, and incubating the intact placenta with the exogenous cells so that the exogenous cells are propagated. 2. The method of…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8986984B2 cover?
- A method of collecting embryonic-like stem cells from a placenta which has been treated to remove residual cord blood by perfusing the drained placenta with an anticoagulant solution to flush out residual cells, collecting the residual cells and perfusion liquid from the drained placenta, and separating the embryonic-like cells from the residual cells and perfusion liquid. Exogenous cells can b…
- Who is the assignee on this patent?
- Hariri Robert J, Anthrogenesis Corp
- What technology area does this patent fall under?
- Primary CPC classification C12N5/0605. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).